5 Best Tech Stocks To Watch Right Now

The Internet offers a bevy of free information to assist one in the formation of a market strategy, however, sometimes it can all seem quite overwhelming, so MoneyShow’s Tom Aspray shares his four favorites.

For those traders or investors who are looking for stocks or ETFs to buy, the wealth of free information on the Internet is quite astounding. It can also be quite intimidating, so I thought I might review four of my favorite sites and how you might use them in your research.

Though my focus is on the technical, I don’t discount the fundamentals, and therefore, one predominantly fundamental site is included in my list. The initial slides were generated on Tuesday afternoon after the announcement was made that US Airways Group, Inc., (LCC) and American Airlines (AAMRQ) reached a settlement allowing their $17 billion dollar merger to go through.

My research path often starts out at www.finviz.com, and the graphic below is a partial screen shot of the home page.  This can give you a quick view of the day’s market action. On the top, there is a ten minute intraday chart of the Dow Industrials, Nasdaq Composite, and S&P 500 (not included). (Editor’s Note; Sections of the entire Web page had to be used so that they would fit appropriately within the article.)

Hot Trucking Stocks To Own Right Now: Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, incorporated in 1983, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company�� radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals, Inc. (Alseres) to license [123I]-E-IACFT Injection, also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson�� disease, movement disorders and dementia. In August 2011, the Company sold its gamma detection device line of business (the GDS Business) to Devicor Medical Products, Inc.

Lymphoseek

Navidea�� pipeline includes clinical-stage radiopharmaceutical agents used to identify the presence and status of disease. Lymphoseek (Kit for the Preparation of Technetium Tc99m for Injection) is a lymph node targeting agent intended for use in intraoperative lymphatic mapping (ILM) procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. The lymph system is a component of the body�� immune system. The key components of the lymph system are lymph nodes-small anatomic structures that contain disease-fighting lymphocytes, filter lymph of bacteria and cancer cells, and signal infection in response to heightened levels of pathogens. In Navidea�� Phase III clinical studies of Lymphoseek, it detected over 99% of positive nodes identified by vital blue dye (VBD). As of December 31, 2011, Navidea, in co-operation with UC, San Diego affiliate (UCSD), completed or initiated five Phase I clinical trials, one multi-center Phase II trial and three multi-center Phase II trials inv! olving Lymphoseek. Two Phase III studies were completed in subjects with breast cancer and melanoma. During the year ended December 31, 2011, data from NEO3-09 were released, which indicated that all primary and secondary endpoints for the study were met. As of December 31, 2011, third Phase III clinical trial for Lymphoseek in subjects with head and neck squamous cell carcinoma (NEO3-06) was in progress.

AZD4694

AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease (AD). It binds to beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD. AZD4694 has been studied in several clinical trials. Clinical studies through Phase IIa have included more than 80 patients to date, both suspected AD patients and healthy volunteers. No significant adverse events have been observed. Results suggest that AZD4694 has the ability to image patients quickly and safely with high sensitivity.

RadioImmunoGuided Surgery

As of December 31, 2011, RIGScan had been studied in a number of clinical trials, including Phase III studies. Navidea has conducted two Phase III studies, NEO2-13 and NEO2-14, of RIGScan in patients with primary and metastatic colorectal cancer, respectively. Both studies were multi-institutional involving cancer treatment institutions in the United States, Israel, and the European Union.

The Company competes with Pharmalucence, Eli Lilly, Bayer Schering, General Electric and GE Healthcare.

Advisors' Opinion:

• [By Sean Williams]

  Another prime example here would be Navidea Biopharmaceuticals' (NYSEMKT: NAVB  ) Lymphoseek which is an injectable agent used in external lymph-node imaging and intra-operative lymphatic mapping. In English this means it will dramatically improve the staging and treatment options for patients with breast cancer. Being that breast cancer was also listed as a commonly misdiagnosed cancer, this is a big step in the right direction for patient care.

• [By Sean Williams]

  Diagnostics can also play an important role in early and late-stage breast cancer diagnoses. Navidea Biopharmaceuticals (NYSEMKT: NAVB  ) had Lymphoseek, its external lymph-node imaging and intra-operative lymphatic mapping diagnostic device, approved by the Food and Drug Administration earlier this year to help doctors stage cancer. Discovering whether breast cancer has invaded adjacent lymph nodes has never been easier or safer thanks to Lymphoseek, and it can dramatically aid physicians in determining the best course of action for breast cancer patients.

5 Best Tech Stocks To Watch Right Now: Ambarella Inc (AMBA)

Ambarella, Inc., incorporated on January 15, 2004, is a developer of semiconductor processing solutions for video that enable high-definition (HD), video capture, sharing and display. The Company combine its processor design capabilities with its video and image processing, algorithms and software to provide a technology platform. It sells solutions into the camera and infrastructure markets, with approximately 27 million system-on-a-chips (SoCs) shipped since our inception. In the camera market, its solutions enable the creation of video content for wearable sports cameras, automotive aftermarket cameras, Internet Protocol (IP), security cameras, digital still cameras (DSCs), telepresence cameras, camcorders and pocket video cameras. In the infrastructure market, its solutions manage IP video traffic, broadcast encoding and IP video delivery applications. In 2012, the Company released its Wireless Camera Developers Kit. In 2012, it also launched S2 SoC, which enables Ultra High-Definition IP security cameras.

The Company sells its solutions to original design manufacturers (ODMs), and original equipment manufacturers (OEMs), globally. In the camera market, its video processing solutions are designed into products from OEMs, including Robert Bosch GmbH and affiliated entities, Samsung Electronics Co., Ltd. and Woodman Labs, Inc., doing business as (d/b/a) GoPro, or GoPro, who source its solutions from ODMs, including Ability Enterprise Co., Ltd., Asia Optical Co. Inc., Chicony Electronics Co., Ltd., DXG Technology Corp., Hon Hai Precision Industry Co., Ltd. and Sky Light Digital Ltd. In the infrastructure market, its solutions are designed into products from OEMs, including Harmonic Inc., Motorola Mobility, Inc. (owned by Google, Inc.) and Telefonaktiebolaget LM Ericsson, who source its solutions from ODMs, such as Plexus Corp.

AmbaClear

The Company�� image signal processing architecture, known as AmbaClear, incorporates advanced algorithms to convert raw senso! r data to high-resolution still and high-definition video images concurrently. Image processing algorithms include sensor, lens and color correction, demosaicing, which is a process used to reconstruct a full color image from incomplete color samples, noise filtering, detail enhancement and image format conversion.

AmbaCast

The Company�� HD video processing architecture, known as AmbaCast, incorporates advanced algorithms for motion estimation, motion-compensated temporal filtering, mode decision and rate control. It supports all three compression profilesbaseline, main and highas specified in the H.264 standard. Its solutions for the broadcast infrastructure market allow OEMs to offer both the H.264 and MPEG-2 encoding formats.

Design Methodology

The Company test and verify its algorithms on its architectural model prior to implementing algorithms in hardware. Its advanced verification methodology validates its approach through simultaneous modeling of architecture, algorithms and the hardware itself.

SoC Solution

The Company�� SoC designs integrate HD video processing, image processing, applications processing and system functions onto a single chip, delivering video and image quality with features, including advanced wireless connectivity. In addition, its SoCs integrate mixed signal (analog/digital) functionality and high speed interfaces required for interfacing to advanced high-speed CMOS sensors and industry standard interfaces, such as USB 2.0 and HDMI 1.4. Its A7L SoC, which it introduced in September 2011, is fabricated in edge 32 nanometer (nm) process technology and integrates AmbaClear and AmbaCast technology.

Software Development Kit for Connectivity

The Company�� video streaming technology enables the camera�� image to be previewed on a smartphone. To enable this functionality, end customers deploy its Wireless Camera Developer�� Kit, or the Kit, which enables the design of ca! meras tha! t combine still photography and Full HD video with wireless video streaming to smartphones. The Kit is available for its A7L SoC product family, providing full 1080p60 HD video with photography and low power consumption.

The Company competes with CSR Plc, Fujitsu Limited, HiSilicon Technologies Co., Ltd., Texas Instruments Incorporated, Canon Inc., Panasonic Corporation, Sony Corporation, Novatek Microelectronics Corp., Sunplus Technology Co. Ltd., Intel Corporation, Magnum Semiconductor, Inc., Texas Instruments Incorporated, Broadcom Corporation, NVIDIA Corporation, Qualcomm Incorporated and Samsung.

Advisors' Opinion:

• [By Rick Munarriz]

  I've suggested that investors buy Ambarella (NASDAQ: AMBA  ) instead of GoPro. It's the lone provider of�video compression and image processing semiconductors for GoPro's cameras, but Ambarella isn't hogtied to GoPro's popularity. Ambarella's presence in Dropcam surveillance cameras and a recent deal for Google Helpouts provide diversification in high-def cameras.�

• [By MONEYMORNING]

  We're talking about the Santa Clara, Calif.-based Ambarella Inc. (Nasdaq: AMBA), whose video-chip technology is finding its way into security cameras, automotive cameras, and the "wearable" video cams the "extreme sports" crowd uses to record their often-breathtaking exploits.

5 Best Tech Stocks To Watch Right Now: Veeva Systems Inc (VEEV)

Veeva Systems Inc. (Veeva), incorporated on January 12, 2007, which provides industry-specific, cloud-based software solutions for the life sciences industry. Veeva delivers industry-specific cloud-based solutions including data, software, and services to the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies. As of January 31, 2013, it served 51, 95 and 134 life sciences customers, respectively. As of August 31, 2013, it served approximately 170 life sciences customers, including 33 of the 50 largest global pharmaceutical companies. Its solutions have been implemented in over 75 countries.

Regulated, Multi-channel Customer Relationship Management

Veeva CRM, its solution for customer relationship management, allows pharmaceutical and biotechnology companies to market and sell to physicians, other healthcare providers and healthcare organizations. Additional applications for the Veeva CRM solution include: Veeva CLM, provides closed-loop marketing capabilities for use in face-to-face interactions with physicians; Veeva iRep, mobile application that runs on the Apple iPad, combines the key functionality of Veeva CRM and Veeva CLM to provide users with functionality that helps maximize productivity in the field, and Veeva CRM Approved Email, provides for the management, delivery and tracking of regulatory compliant email communication between sales representatives and physicians.

Regulated Content Management and Collaboration

Veeva Vault, its cloud-based content management and collaboration solution, is used by its customers to manage content-centric processes across key departments within a life sciences company, including clinical trials, quality management, manufacturing, sales and marketing. Veeva Vault applications primarily for use by research and development departments of life sciences companies include: Veeva Vault eTMF, is an electronic trial master file application that manages the reposit! ory of important documents for active and archived clinical trials. In addition, Vault eTMF also enables collaboration between the life sciences company sponsoring the trial and its outsourced partners such as CROs; Veeva Vault Investigator Portal, manages the collection of documentation and collaboration among trial sponsors, trial sites and the researchers conducting the trials, known as investigators; Veeva Vault Submissions, life sciences companies to gather and organize all the documents and other content that will be included in a regulatory submission to a healthcare authority, such as the Food & Drug Administration (FDA), and Veeva Vault QualityDocs enables the creation, review, approval, distribution and management of controlled documents, such as SOPs, manufacturing recipes and specifications. The Veeva Vault applications primarily for use by commercial departments of life sciences companies include: Veeva Vault PromoMats manages the end-to-end process for the development, approval, distribution, expiration and withdrawal of promotional materials. and Veeva Vault MedComms provides life sciences companies with a single, validated source of medical content across multiple channels and geographies.

Customer Master Data Management

Veeva Network, its cloud-based customer master solution, is designed to help life sciences companies create and maintain a single, complete and accurate record of the healthcare professionals and healthcare organizations with which they interact. Veeva Network is comprised of data, software and services: Veeva Network Provider Database is Veeva�� database of healthcare professionals and healthcare organizations in the United States and China including demographic and license information, affiliations and other key profile data; Veeva Network Provider Database is Veeva�� database of healthcare professionals and healthcare organizations in the United States and China including demographic and license information, affiliations and other key ! profile d! ata, and Veeva Network Data Stewardship Services managing healthcare professional and healthcare organization data.

Professional Services and Support

In addition to cloud-based solutions that meet the specific needs of its life sciences customers, it also offer professional services to help customers maximize the value they get from those solutions. It offers professional services in areas of: implementation and deployment planning and project management; requirements analysis, solution design and configuration; systems environment management and deployment services; training on its solutions, and ongoing managed services, such as outsourced systems administration.

The Company competes with Oracle Corporation, Cegedim SA, EMC Corporation, Microsoft Corporation and OpenText Corporation.

Advisors' Opinion:

• [By John Udovich]

  Biotech bubble talk, news�about Veeva Systems Inc (NYSE: VEEV) and TNI BioTech (OTCMKTS: TNIB), and�recent biotech IPO filings by Ruthigen (NASDAQ: RTGN), Aerie Pharmaceuticals (NASDAQ: AERI) and Egalet (NASDAQ: EGLT) are dominating the latest biotech industry headlines:�

5 Best Tech Stocks To Watch Right Now: NetQin Mobile Inc. (NQ)

NetQin Mobile Inc. operates as a software-as-a-service provider of consumer-centric mobile Internet services focusing on security and productivity in the People?s Republic of China and internationally. It provides a suite of mobile Internet services that protect mobile users from security threats and enhance their productivity. It offers mobile security services, including mobile malware scanning, Internet firewall, account and communication safety, anti-theft, performance optimization, hostile software rating and reporting, and other services to protect users from mobile malware threats, data theft, and privacy intrusion. The company also provides mobile productivity services comprising screening incoming calls, filtering unwanted spam, SMS messages, protecting communication privacy, and managing calendar activities, as well as cloud-side synchronization of personal data, including address books, text messages, and calendars to enhance time and relationship management. In addition, it provides personalized intelligent cloud services that utilize synchronized user information to provide tailored user experience and extend the functionalities of its core services. Further, the company offers security forums and download services for third-party mobile applications. The company was founded in 2005 and is based in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By Garrett Cook]

  Telecommunications services shares gained around 0.25 percent in today’s trading. Top gainers in the sector included NQ Mobile (NYSE: NQ), Allot Communications (NASDAQ: ALLT), and SK Telecom Co (NYSE: SKM).

• [By James E. Brumley]

  What do Joe's Jeans Inc. (NASDAQ:JOEZ) and NQ Mobile Inc. (NYSE:NQ) have in common? Well, nothing ... at least on the surface. JOEZ is, as the name would imply, a denim company, while NQ, as the name would vaguely suggest, a mobile internet service provider. There is one common element between the two companies right now, however, at least in my eyes ... both are likely to be at the beginning of major (read "trade-worthy") bounces.

• [By Paul Ausick]

  Chinese Internet service provider NQ Mobile Inc. (NYSE: NQ) was attacked by short selling firm Muddy Waters LLC in late October and the company�� share price tumbled from a 52-week high of $25.90 to less than $9.00. The company has been clawing its way back up ever since, and got another boost on Friday after independent equity analysis firm Wedge Partners tweeted that NQ Mobile has been able to restore the company�� games to the Apple Inc. (NASDAQ: AAPL) App Store.